{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:24:25Z","timestamp":1787019865083,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Patients with a history of myocardial infarction (MI) are often at risk for complications, including subsequent MI and death. Use of prognostic markers may aid in preventing these poor outcomes. Hyperuricemia is associated with increased risk for coronary heart disease (CHD) and\/or mortality; however, it is unknown if serum urate (sUA) levels predict outcomes in patients with previous MI. The purpose of this study was to assess hyperuricemia as a biomarker of CHD outcomes in such patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>These were post hoc analyses of datasets from the Aspirin Myocardial Infarction Study, a 1:1 randomized, double-blind clinical trial, conducted from 1975 to 1979, that examined mortality rates following daily aspirin administration over three years in individuals with documented MI. The primary outcome measures were all-cause death, CHD mortality, coronary incidence, and stroke by quartile of baseline sUA. A sub-analysis of all outcome measures in the presence or absence of gouty arthritis was also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 4,524 enrolled participants, data on 4,352 were analyzed here. All outcomes were greatest for patients in the fourth sUA quartile. In multivariate regression models, the hazard ratios (HR) for patients in the highest quartile were 1.88 for all-cause mortality (95% confidence interval (CI), 1.45 to 2.46), 1.99 for CHD mortality (95% CI, 1.49 to 2.66), and 1.36 for coronary incidence (95% CI, 1.08 to 1.70). Participants with untreated gout had an adjusted hazard ratio ranging from 1.5 to 2.0 (all\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01) for these outcomes. Participants with gout who were receiving treatment did not exhibit this additional risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>sUA and untreated gout may be independent prognostic markers for poor all-cause and CHD mortality in patients with recent acute MI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/ar3684","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T02:33:16Z","timestamp":1326853996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction"],"prefix":"10.1186","volume":"14","author":[{"given":"Eswar","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavik J","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharathi","family":"Lingala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Dabbous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"3457_CR1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","volume":"121","author":"D Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, et al: Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010, 121: 948-954.","journal-title":"Circulation"},{"key":"3457_CR2","doi-asserted-by":"publisher","first-page":"13G","DOI":"10.1016\/j.amjcard.2008.06.006","volume":"102","author":"CP Cannon","year":"2008","unstructured":"Cannon CP, Greenberg BH: Risk stratification and prognostic factors in the post-myocardial infarction patient. Am J Cardiol. 2008, 102: 13G-20G. 10.1016\/j.amjcard.2008.06.006.","journal-title":"Am J Cardiol"},{"key":"3457_CR3","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1001\/jama.286.19.2405","volume":"286","author":"DA Morrow","year":"2001","unstructured":"Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, Robertson DH, Hille DA, DeLucca PT, DiBattiste PM, Demopoulos LA, Weintraub WS, Braunwald E: Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA. 2001, 286: 2405-2412. 10.1001\/jama.286.19.2405.","journal-title":"JAMA"},{"key":"3457_CR4","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1373\/clinchem.2007.090613","volume":"53","author":"PA Kavsak","year":"2007","unstructured":"Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS: Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem. 2007, 53: 2112-2118. 10.1373\/clinchem.2007.090613.","journal-title":"Clin Chem"},{"key":"3457_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.clinbiochem.2006.10.025","volume":"40","author":"PA Kavsak","year":"2007","unstructured":"Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS: Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clin Biochem. 2007, 40: 326-329. 10.1016\/j.clinbiochem.2006.10.025.","journal-title":"Clin Biochem"},{"key":"3457_CR6","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/ar3322","volume":"13","author":"E Krishnan","year":"2011","unstructured":"Krishnan E, Pandya BJ, Chung L, Dabbous O: Hyperuricemia and the risk for subclinical coronary atherosclerosis-data from a prospective observational cohort study. Arthritis Res Ther. 2011, 13: R66-10.1186\/ar3322.","journal-title":"Arthritis Res Ther"},{"key":"3457_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.amjmed.2005.03.043","volume":"118","author":"JF Baker","year":"2005","unstructured":"Baker JF, Krishnan E, Chen L, Schumacher HR: Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?. Am J Med. 2005, 118: 816-826. 10.1016\/j.amjmed.2005.03.043.","journal-title":"Am J Med"},{"key":"3457_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11926-008-0039-0","volume":"10","author":"E Krishnan","year":"2008","unstructured":"Krishnan E: Gout and coronary artery disease: epidemiologic clues. Curr Rheumatol Rep. 2008, 10: 249-255. 10.1007\/s11926-008-0039-0.","journal-title":"Curr Rheumatol Rep"},{"key":"3457_CR9","doi-asserted-by":"crossref","unstructured":"A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA. 1980, 243: 661-669.","DOI":"10.1001\/jama.243.7.661"},{"key":"3457_CR10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1056\/NEJMoa035700","volume":"350","author":"HK Choi","year":"2004","unstructured":"Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004, 350: 1093-1103. 10.1056\/NEJMoa035700.","journal-title":"N Engl J Med"},{"key":"3457_CR11","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1001\/archinte.1997.00440340060005","volume":"157","author":"AC Gelber","year":"1997","unstructured":"Gelber AC, Klag MJ, Mead LA, Thomas J, Thomas DJ, Pearson TA, Hochberg MC: Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med. 1997, 157: 1436-1440. 10.1001\/archinte.1997.00440340060005.","journal-title":"Arch Intern Med"},{"key":"3457_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3899\/jrheum.100418","volume":"38","author":"MA McAdams","year":"2011","unstructured":"McAdams MA, Maynard JW, Baer AN, Kottgen A, Clipp S, Coresh J, Gelber AC: Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol. 2011, 38: 135-141. 10.3899\/jrheum.100418.","journal-title":"J Rheumatol"},{"key":"3457_CR13","first-page":"1646","volume":"33","author":"N Dalbeth","year":"2006","unstructured":"Dalbeth N, Kumar S, Stamp L, Gow P: Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol. 2006, 33: 1646-1650.","journal-title":"J Rheumatol"},{"key":"3457_CR14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.4065\/81.7.925","volume":"81","author":"CA Sarawate","year":"2006","unstructured":"Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW: Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc. 2006, 81: 925-934. 10.4065\/81.7.925.","journal-title":"Mayo Clin Proc"},{"key":"3457_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000239860","volume":"114","author":"Y Brodov","year":"2009","unstructured":"Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S: Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology. 2009, 114: 300-305. 10.1159\/000239860.","journal-title":"Cardiology"},{"key":"3457_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/art.23121","volume":"58","author":"AG Ioachimescu","year":"2008","unstructured":"Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ: Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 2008, 58: 623-630. 10.1002\/art.23121.","journal-title":"Arthritis Rheum"},{"key":"3457_CR17","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/archinternmed.2010.198","volume":"170","author":"G Thanassoulis","year":"2010","unstructured":"Thanassoulis G, Brophy JM, Richard H, Pilote L: Gout, allopurinol use, and heart failure outcomes. Arch Intern Med. 2010, 170: 1358-1364. 10.1001\/archinternmed.2010.198.","journal-title":"Arch Intern Med"},{"key":"3457_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/art.24612","volume":"61","author":"SY Kim","year":"2009","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA: Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009, 61: 885-892. 10.1002\/art.24612.","journal-title":"Arthritis Rheum"},{"key":"3457_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/art.24164","volume":"61","author":"JH Chen","year":"2009","unstructured":"Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH: Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009, 61: 225-232. 10.1002\/art.24164.","journal-title":"Arthritis Rheum"},{"key":"3457_CR20","unstructured":"The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group. Circulation. 1980, 62: V79-84."},{"key":"3457_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C","volume":"43","author":"D Caspi","year":"2000","unstructured":"Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R: The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000, 43: 103-108. 10.1002\/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C.","journal-title":"Arthritis Rheum"},{"key":"3457_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1023\/B:CARD.0000015855.02485.e3","volume":"17","author":"AJ Reyes","year":"2003","unstructured":"Reyes AJ: Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther. 2003, 17: 397-414.","journal-title":"Cardiovasc Drugs Ther"},{"key":"3457_CR23","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/rheumatology\/keq037","volume":"49","author":"E Krishnan","year":"2010","unstructured":"Krishnan E: Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford). 2010, 49: 1229-1238. 10.1093\/rheumatology\/keq037.","journal-title":"Rheumatology (Oxford)"},{"key":"3457_CR24","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ: Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003, 41: 1287-1293. 10.1161\/01.HYP.0000072820.07472.3B.","journal-title":"Hypertension"},{"key":"3457_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/15257770902736400","volume":"28","author":"C Gersch","year":"2009","unstructured":"Gersch C, Palii SP, Imaram W, Kim KM, Karumanchi SA, Angerhofer A, Johnson RJ, Henderson GN: Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids. 2009, 28: 118-149. 10.1080\/15257770902736400.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"3457_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","volume":"26","author":"DB Corry","year":"2008","unstructured":"Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML: Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008, 26: 269-275. 10.1097\/HJH.0b013e3282f240bf.","journal-title":"J Hypertens"},{"key":"3457_CR27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1681\/ASN.2006030264","volume":"17","author":"KL Price","year":"2006","unstructured":"Price KL, Sautin YY, Long DA, Zhang L, Miyazaki H, Mu W, Endou H, Johnson RJ: Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol. 2006, 17: 1791-1795. 10.1681\/ASN.2006030264.","journal-title":"J Am Soc Nephrol"},{"key":"3457_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/hy1101.092839","volume":"38","author":"M Mazzali","year":"2001","unstructured":"Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001, 38: 1101-1106. 10.1161\/hy1101.092839.","journal-title":"Hypertension"},{"key":"3457_CR29","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","volume":"114","author":"J George","year":"2006","unstructured":"George J, Carr E, Davies J, Belch JJ, Struthers A: High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006, 114: 2508-2516. 10.1161\/CIRCULATIONAHA.106.651117.","journal-title":"Circulation"},{"key":"3457_CR30","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.amjcard.2004.06.032","volume":"94","author":"G Mercuro","year":"2004","unstructured":"Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, Rosano GM: Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol. 2004, 94: 932-935. 10.1016\/j.amjcard.2004.06.032.","journal-title":"Am J Cardiol"},{"key":"3457_CR31","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/01.CIR.0000144303.24894.1C","volume":"110","author":"N Engberding","year":"2004","unstructured":"Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Muller M, Fuchs M, Hilfiker-Kleiner D, Hornig B, Drexler H, Landmesser U: Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?. Circulation. 2004, 110: 2175-2179. 10.1161\/01.CIR.0000144303.24894.1C.","journal-title":"Circulation"},{"key":"3457_CR32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00005344-200305000-00005","volume":"41","author":"W Guan","year":"2003","unstructured":"Guan W, Osanai T, Kamada T, Hanada H, Ishizaka H, Onodera H, Iwasa A, Fujita N, Kudo S, Ohkubo T, Okumura K: Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J Cardiovasc Pharmacol. 2003, 41: 699-705. 10.1097\/00005344-200305000-00005.","journal-title":"J Cardiovasc Pharmacol"},{"key":"3457_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ijcard.2009.08.037","volume":"145","author":"E Rentoukas","year":"2010","unstructured":"Rentoukas E, Tsarouhas K, Tsitsimpikou C, Lazaros G, Deftereos S, Vavetsi S: The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2010, 145: 257-258. 10.1016\/j.ijcard.2009.08.037.","journal-title":"Int J Cardiol"},{"key":"3457_CR34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/140174300750064549","volume":"34","author":"MR Tarkka","year":"2000","unstructured":"Tarkka MR, Vuolle M, Kaukinen S, Holm P, Eloranta J, Kaukinen U, Sisto T, Kataja J: Effect of allopurinol on myocardial oxygen free radical production in coronary bypass surgery. Scand Cardiovasc J. 2000, 34: 593-596. 10.1080\/140174300750064549.","journal-title":"Scand Cardiovasc J"},{"key":"3457_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jama.300.8.924","volume":"300","author":"DI Feig","year":"2008","unstructured":"Feig DI, Soletsky B, Johnson RJ: Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008, 300: 924-932. 10.1001\/jama.300.8.924.","journal-title":"JAMA"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3684\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:26:57Z","timestamp":1728368817000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,2]]}},"alternative-id":["3457"],"URL":"https:\/\/doi.org\/10.1186\/ar3684","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,17]]},"assertion":[{"value":"13 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R10"}}